Cyclosporine-ketoconazole combination offers promise in reducing antirejection therapy costs.
Randall
T
T
D003365:Costs and Cost Analysis; D003524:Cyclosporins / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D007654:Ketoconazole / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000191:economics*
D003524:Cyclosporins; D007654:Ketoconazole